Kjersti Tjensvoll

Stavanger, 4068, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway.

Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway.

Journal: Clinical and experimental medicine

Published: December 05, 2025

Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics.

Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics.

Journal: Molecular oncology

Published: July 11, 2025

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer.

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer.

Journal: Molecular oncology

Published: May 02, 2025

Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer.

Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer.

Journal: PloS one

Published: May 15, 2023

Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging.

Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging.

Journal: Molecular oncology

Published: February 28, 2023

Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer.

Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 15, 2022

Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study.

Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study.

Journal: BMJ open

Published: April 29, 2022

Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study.

Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study.

Journal: BMC cancer

Published: January 14, 2022

Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing.

Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing.

Journal: Scientific reports

Published: November 22, 2021

Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System.

Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System.

Journal: Cancers

Published: March 03, 2021

Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients.

Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients.

Journal: BMC cancer

Published: October 15, 2018

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer.

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer.

Journal: Journal of translational medicine

Published: September 05, 2018

Showing 1-12 of 26

Last Updated: 09/26/2026